Abstract
The activity of LJC10,627 was compared with the activities of imipenem and other antibiotics. LJC10,627 was more active against most members of the family Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. but slightly less active than imipenem against staphylococci and streptococci. LJC10,627 showed stability to mouse dehydropeptidase I and was more effective in vivo than imipenem plus cilastatin against gram-negative bacterial infections and as effective against staphylococcal infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Campbell B. J., Lin Y. C., Davis R. V., Ballew E. The purification and properties of a particulate renal dipeptidase. Biochim Biophys Acta. 1966 May 5;118(2):371–386. doi: 10.1016/s0926-6593(66)80046-2. [DOI] [PubMed] [Google Scholar]
- Kahan F. M., Kropp H., Sundelof J. G., Birnbaum J. Thienamycin: development of imipenen-cilastatin. J Antimicrob Chemother. 1983 Dec;12 (Suppl 500):1–35. doi: 10.1093/jac/12.suppl_d.1. [DOI] [PubMed] [Google Scholar]
- Lipman B., Neu H. C. Imipenem: a new carbapenem antibiotic. Med Clin North Am. 1988 May;72(3):567–579. doi: 10.1016/s0025-7125(16)30759-3. [DOI] [PubMed] [Google Scholar]
- Wang C., Calandra G. B., Aziz M. A., Brown K. R. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience. Rev Infect Dis. 1985 Jul-Aug;7 (Suppl 3):S528–S536. doi: 10.1093/clinids/7.supplement_3.s528. [DOI] [PubMed] [Google Scholar]
- Wise R. In vitro and pharmacokinetic properties of the carbapenems. Antimicrob Agents Chemother. 1986 Sep;30(3):343–349. doi: 10.1128/aac.30.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]